Search Results 181-190 of 8451 for Conduction

  1. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

    No active conduction system abnormalities; No other malignancy within the past 3 years, except for the following: Completely resected basal cell or squamous ...

  2. Congenital heart defects in children - Doctors and departments - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  3. Neurology - Doctors - Mayo Clinic

    Electromyography, Nerve block, Ultrasound, Nerve conduction study, Ultrasound-guided cortisone injection, Ultrasound-gu...ided injection, Ultrasound-guided ...

  4. Congenital heart defects in children - Doctors and departments - Mayo Clinic

    ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

  5. Atrial fibrillation ablation - Doctors & Departments - Mayo Clinic

    ... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Abhishek J. Deshmukh, M.B.B.S.. Cardiologist ...

  6. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

    Major conduction abnormality (unless a cardiac pacemaker is present). Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

  7. Publications - Lauren B. Querin, M.D., M.Ed. - Mayo Clinic

    2024; 36(1):102039. Van Ligten MJ, Rappaport DE, Querin LB, Martini WA. Atrial Septal Defect (ASD) Repair Unveiling an Unusual Conduction Conundrum: A ...

  8. ... CONDUCTION DISORDERS WITH MCC,46841.48 MS309,CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC,25658.4 MS310,CARDIAC ARRHYTHMIA AND CONDUCTION ...

  9. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    ... conduction abnormality not controlled by adequate medication -Angina pectoris requiring anti-angina medication -Clinically significant valvular heart ...

  10. Transcatheter Aortic Valve Replacement (TAVR) Clinical Trials - Mayo Clinic Research

    Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 Rochester, MN. The purpose of this study is to establish the safety of using Cara™ Monitor used in TAVR ...